Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer.
Yung-Sung YehHsiang-Lin TsaiPo-Jung ChenYen-Cheng ChenWei-Chih SuTsung-Kun ChangChing-Wen HuangJaw-Yuan WangPublished in: Expert review of molecular diagnostics (2023)
Clinical trials documenting the effect of immune checkpoints were performed to produce long-lasting effects for patients with mCRC. Consequently, therapeutic decision-making models are further refined by the inclusion of powerful molecular biomarkers in patients with CRC.